ArticlePharmaceuticals (Basel, Switzerland)2026
Refined Jianpi Huayu Jiedu Decoction Attenuates TAM-Induced Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) by Modulating LCN2-Associated Mitochondrial Dysfunction.
Chongkai Fang, Sijia Zhang, Peiyao He, Yongheng Lai, Rui Luo, Yunshuo Zhang, Sida Liu, Zichun Xie, Huafeng Pan, Wei Liu
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Chongkai FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0000-0001-8319-5189 Sijia ZhangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Peiyao HeScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Yongheng LaiThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Rui LuoThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Yunshuo ZhangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Sida LiuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Zichun XieScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Huafeng PanScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Wei LiuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0000-0003-3738-5218 Funding
China Postdoctoral Science Foundation 2024M750666Department of Education of Guangdong Province 2023KCXTD080Guangdong Province Natural Science Foundation Management Committee 2023A1515011107Guangdong Province Natural Science Foundation Management Committee 2024A1515030250National Natural Science Foundation of China No.82374343National Natural Science Foundation of China No.82405319the Key Research and Development Program of Guangzhou Municipal Science and Technology Project 2025B01J3012
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
JHJDLCN2mitochondrial dysfunctionSPEM
Identifiers
PMID42198341
PMCPMC13209456
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390